RAC 2.92% $1.59 race oncology ltd

Ann: Race releases cardioprotection market potential data, page-211

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,874 Posts.
    lightbulb Created with Sketch. 2903
    didn’t even need to take it through to approval, Sheba 1 and done! basically Playmaker got in early and left to rinse and repeat with ILA and FRE for PM.

    So where does this leave Race, we’ll still only biotech geeks are interested, KOL seem to be bitting with Cardio protect but we haven’t seen anything on the FTO front. Perhaps they need to chuck a Keytruda and take out a full page advert in the Wall Street Journal?

    I tend to observe market cycle is usually, Playmakers, geeks, sophs/brokers followed by Instos and retail (sheep). So we are early to the party no one has shown up yet. No news is not good news, no news is no news and the market needs some confidence at the moment not just in biotech. For this reason its a waiting game.

    When Pharma start buying up I think that’s when the biotech tech sector will get some momentum. They can’t sit on their huge mountains of cash forever!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.